Langford CA, et al. (2025). A Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis. Arthritis Rheumatol, 77(12): 1739-1748.

Chu ES, et al. (2022). Implementation of an electronic health record based medication reconciliation risk stratification tool: A case series of three academic medical centers. Healthcare (Amsterdam, Netherlands), 10(4):100654.

Gorelik M, et al. (2022). 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the management of Kawasaki Disease. Arthritis Rheum, 74(4):586.

Chung S, et al. (2021). 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. Arthritis Rheum, 73(8):1366.

Chung S, et al. (2021). American College of Rheumatology/Vasculitis Foundation Guideline for the management of polyarteritis nodosa. Arthritis Care Res, 73(8):1384.

Dada L, et al (2021). Microscopic polyangiitis with diffuse alveolar hemorrhage and glomerulonephritis complicating acute influenza infection. J Clin Rheum: Pract Rep Rheumatic Musculoskeletal Dis, 27(8S), S618.

Dua A, et al. (2021). Takayasu Arteritis: A systematic review and meta‐analysis of test accuracy and benefits and harms of common treatments. ACR Open Rheuml, 3(2):100.

Feldman M, et al. (2021). Pre-clerkship physical exam assessment rubric. Clin Teach, 18:69.

Lin, YC, et al. (2021). Polyarteritis nodosa: A systematic review of test accuracy and benefits and harms of common treatments. ACR Open Rheum, 3(2):91.

Maz M, et al. (2021). 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the management of giant cell arteritis and Takayasu Arteritis. Arthritis Rheum, 3(8):1349.

Schnipper JL, et al. (2021). Effects of a refined evidence-based toolkit and mentored implementation on medication reconciliation at 18 hospitals: results of the MARQUIS2 study. BMJ qual safe, 31(4), 278.

Springer J, et al. (2021). Eosinophilic granulomatosis with polyangiitis: A systematic review and meta‐analysis of test accuracy and benefits and harms of common treatments. ACR Open Rheum, 3(2):100.

Springer J, et al. (2021). Granulomatosis with polyangiitis and microscopic polyangiitis: A systematic review and meta‐analysis of benefits and harms of common treatments. , 3(3):196.

Ying D, et al. (2021). Inorganic dust exposure during military service as a predictor of rheumatoid arthritis and other autoimmune conditions. ACR Open Rheum, 3(7):466.

Liebowitz JE, et al. (2020). Rheumatology milestones 2.0: A roadmap for competency-based medical training of rheumatology fellows in the 21^st century. Arthritis Rheum: Arthritis Care Res (Hoboken), 74(4): 675.

Weilg P, et al. (2020). Amnesia in a patient with rheumatoid arthritis: A case of granulomatosis with polyangiitis. Case Rep Rheum, 8844951.

Ying D, et al. (2020). Increased risk of ischemic stroke in systemic sclerosis: A national cohort study of US veterans. J Rheum, 47(1):82.

Cuenca JA, et al. (2019). Febuxostat and cardiovascular events: A systematic review and meta-analysis. Int J Rheum, 2019(1076189).

Mixon AS, et al. (2019). Design of MARQUIS2: study protocol for a mentored implementation study of an evidence-based toolkit to improve patient safety through medication reconciliation. BMC Health Serv Res 19:659.

Dalal DS, et al. (2018). Efficacy and safety of biological agents in the older rheumatoid arthritis patients compared to young: A systematic review and meta-analysis. Semin Arthritis Rheum, 18.

Kushner T, et al. (2018). New presentation of autoimmune hepatitis with erythema multiforme. Hepatology, 67(4):1628.

Carter JD and Hudson AP (2017).  Recent advances and future directions in understanding and treating Chlamydia-induced reactive arthritis. Expert Rev Clin Immunol, 13(3):196.

Criscione-Schreiber LG, et al. (2017). A new roadmap for the journey from internist to rheumatologist. Arthritis Care Res (Hoboken). 69(6):765.

Phung L, et al. (2017). Parallel ocular and serologic course in a patient with early Sjogrens’s syndrome markers. Am J Ophthalmol Case Rep, 8:48.

Raturi R, et al. (2017). Two cases demonstrating thalidomide’s efficacy in refractory lupus nephritis. Clin Rheum, 36(3):725.

Brown CR, et al. (2016). What is a rheumatologist and how do we make one. Arthritis Care Res (Hoboken). 68(8):1166.

Mease PJ, et al. (2016). Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1. Ann Rheum Dis, 209709.

Brophy RH, et al. (2015). Association of meniscal status, lower extremity alignment, and body mass index with chondrosis at revision anterior cruciate ligament reconstruction. Am J Sports Med, 43(7):1616.

Carter JD, et al. (2015). An MRI assessment of chronic synovial-based inflammation in gout and its correlation with serum urate levels. Clin Rheum, 34(2):345.

Carter JD, et al. (2015). An MRI assessment of the response of chronic, occult, synovial-based inflammation of gout to serum urate lowering therapy. J Rheumatic Dis Treat, 1:019.

Chen X, et al. (2015). Inactivation of DAP12 in PMN inhibits TREM1-mediated activation in rheumatoid arthritis. PLoS One, 10(2):e0115116.

Dalal D, et al. (2015). Quantifying Harmful Effects of Psoriatic Diseases on Quality of Life: Cardio-metabolic outcomes in psoriatic arthritis study (COMPASS). Sem Arthritis Rheumatism, 44(6):641.

Lohr KM, et al. (2015). Relationship between performance on the Rheumatology in-training and certification examinations. Arthritis Rheum, 67(11):3082.

Matava MJ, et al. (2015). Multirater agreement of the causes of anterior cruciate ligament reconstruction failure: a radiographic and video analysis of the MARS cohort. Am J Sports Med, 43(2):310.

Sapir T, et al. (2015). Influence of Continuing Medical Education on Rheumatologists' Performance on National Quality Measures for Rheumatoid Arthritis. Rheum Ther, 2(2):141.

Cuchacovich R, et al. (2014). Distinct genetic profile in peripheral blood mononuclear cells of psoriatic arthritis patients treated with methotrexate and TNF-inhibitors. Clin Rheum, 33(12):1815.

Carter JD, et al. (2014). An Assessment of Chronic Synovial-Based Inflammation in Gout and its Correlation with Serum Urate Levels. Clin Rheum, 34:345.

Garcia C, et al. (2014). The Potential Causality of the Microbiome and Infectious Pathogens in Primary Vasculitis. Curr Clin Microbio Rep, 1:73.

Genovese M, et al. (2014). Efficacy and Safety of Olokizumab in Rheumatoid Arthritis Patients with an Inadequate Response TNF Inhibitor Therapy: Outcomes of a Phase IIb Study. Ann Rheumatic Dis, 73(9):1607.

Lin YC, et al. (2014). Relationship between metabolic syndrome and carotid intima  media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis. Arthritis Care Res (Hoboken), 66(1):97.

MARS Group (2014). Osteoarthritis classification scales: interobserver reliability and arthroscopic correlation. J Bone Joint Surg, 96(14):1145.

Perez-Alamino R, et al. (2014). Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease? Rheuml Int, 34:1211.

Nair N, et al. (2024). Mycophenolate Mofetil in the Treatment of Patients with Isolated Cardiac Sarcoidosis. American College of Rheumatology Meeting, Washington DC.

Bagrova A, (2022). A disfiguring Guest from the Past: A Case of Hansen’s Disease in a Young Woman. The Florida Society of Rheumatology (FSR), Orlando FL.

Holguin Balbuena S, et al. (2022). Clinical Outcomes of COVID-19 Vaccination and Booster in Patients with Autoimmune Inflammatory Rheumatic Disease. ACR Scientific Convergence. Arthritis Rheumatol, 74 (suppl 9).

Shahin A, et al. (2022). A case of COVID-19 associated Necrotizing Autoimmune Myopathy Improved with Immunosuppressive Therapy. The Florida Society or Rheumatology (FSR), Orlando, FL.

Dhamankar O, et al. (2021). Catastrophic Antiphospholipid Antibody Syndrome: Thrombosis in an Anticoagulated Patient with Antiphospholipid Antibody Syndrome and COVID-19. Dade County Medical Association Residents Research Symposium.

Cao S, Lin YC (2020). Outcome of Giant Cell Arteritis Patients Who Were Primarily Admitted for Venous Thromboembolism Events. American College of Rheumatology, ACR Convergence.

Cao S, Lin YC (2020). Thirty-Day Readmission Rate in Patients Who Were Initially Admitted for Active Giant Cell Arteritis. American College of Rheumatology, ACR Convergence.

Figueroa-Sierra M, et al. (2020). Improving Glucocorticoid Induced Osteoporosis Screening and Management in Patients with Rheumatic Diseases Using the 2017 ACR Guidelines. ACR Scientific Convergence. Arthritis Rheumatol, 72 (suppl 9).

Joseph D, et al. (2020). Neuro-Behcet’s Mimicking a Pontine Glioma: A Case Report. PANLAR Congress, Miami, FL.

Sierra MF, et al. (2020). Improving Glucocorticoid-Induced Osteoporosis Screening and Management in Patients with Rheumatic Diseases Using the 2017 ACR Guidelines, American College of Rheumatology, ACR Convergence.

Vafa A, Lin YC (2020). Outcomes of Hospitalizations for Acute Myocardial Infarction in Patients with ANCA Associated Vasculitis from the National Inpatient Sample. American College of Rheumatology, ACR Convergence.

Zamora R, et al. (2020). Is it Lupus? Is it Vasculitis? Is it both? American College of Physicians Florida Chapter Meeting.

Abdulla O, et al. (2019). A comparison between Outcomes of Atherectomy Devices Used in Patients with Infrainguinal Peripheral Vascular Disease.The Society for Cardiovascular and Angiography and Interventions (SCAI), Las Vegas, NV.

Babary H, et al. (2019). Improving the Rate of Tuberculosis Screening Among High Risk

Rheumatoid Arthritis Patients on Biologic Agents Using a Proposed Questionnaire. America College of Rheumatology, Atlanta, Georgia.

Goyal A, et al. (2019). An Uncommon Symptom Constellation in Hidradenitis Suppurativa. Congress of Clinical Rheumatology; San Diego, CA. 

Succari L, et al. (2019). Hypogammaglobulinemia in The Setting of IgA Vasculitis, The Chicken or The Egg?The American College of Asthma, Allergy and Immunology (ACAAI), Houston, TX.

Abdulla O, et al. (2018). Outcomes of Atherectomy in Patients with Infrainguinal Arterial Disease.The American College of Cardiology (ACC), Orlando, FL.

Ying D (2018). Risk of Ischemic Stroke in Veterans with Systemic Sclerosis: A Nationwide Cohort Study. ACR/ARHP Annual Meeting, Chicago, IL.

Dalal D, et al. (2017). Efficacy and Safety of Biologic therapy in Elderly Rheumatoid Arthritis Patients compared to Young – A Systematic Review. EULAR; Madrid, Spain.

Brar T, et al. (2016). A Case of IgG4-related Sclerosing Pachymeningitis. Brown University Research Forum, Providence, RI.

Genovese M, et al. (2016). Improvements in Patient-Reported Outcomes with Olokizumab Treatment in Patients with Active, Moderate to Severe Rheumatoid Arthritis who had Failed Previous Anti-TNF Therapy: Results from the RA0056 Double-Blind, Randomized Controlled Study, and RA0057, Its Open Label Extension. EULAR National Meeting. London, England.

Gina A, et al. (2016). Preliminary Response to JAK1/2 Inhibition with Baricitinib in “Candle”,“Savi” and “Candle-like” Diseases: a New Therapeutic Approach for Type I IFN Mediated Autoinflammatory Diseases. ACR Scientific Meeting. Washington D.C.

Gottlieb AB, et al. (2015). Ixekizumab Improves Physical Function, Quality of Life, and Work Productivity in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients with Active Psoriatic Arthritis. American College of Rheumatology.

Gottlieb AB, et al. (2015). Ixekizumab in Patients with Psoriasis and Psoriatic Arthritis: Pooled Analysis of the Three Phase 3 studies in Moderate-to-Severe Psoriasis. 4^th World Psoriasis & Psoriatic Arthritis.

Mease PJ, et al. (2015). A Randomized, Double-blind, Active- and Placebo-controlled Phase 3 Study of Efficacy and Safety of Ixekizumab, Adalimumab, and Placebo Therapy in Patients Naïve to Biologic Disease modifying Anti-rheumatic Drugs with Active Psoriatic Arthritis. American College of Rheumatology.

Brar T et al. (2014). Posterior Reversible Encephalopathy Syndrome & Scleroderma: New Friends, Old Relationship. AMA Research Symposium, Dallas, TX.

Issa D, et al. (2014). Treatment and Recurrence Patterns of Rectal Cancer in the Elderly. The American College of Physicians (ACP), Columbus, OH.

Oikonomopoulos I, Carter JD (2014). Comparison of C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR) with Estimated Glomerular Filtration Rate (eGFR) in Patients with Rheumatoid Arthritis (RA). ACR Scientific Meeting. Boston, MA.

Papp K, et al. (2014). The effects of ixekizumab treatment in a subset of patients with psoriatic arthritis in a phase 2 study in moderate-to-severe plaque psoriasis. EADV.

Perez-Alamino R, et al. (2014). Is there a role of Inflammasome activation in PsA pathogenesis and its comorbidities? American College of Rheumatology and GRAPPA meetings.

Perez-Alamino R, et al. (2014). Role of Inflammasome Activation in Systemic Lupus Erythematosus: are innate immune cells activated? American College of Rheumatology.